DLH Holdings Q2 FY2026: Navigating Setbacks & Opportunities

DLH Holdings reported a dip in Q2 FY2026 revenue at $59.3 million, down from $89.2 million last year, due to program shifts to small business set-asides. However, they maintained a solid 9% adjusted EBITDA margin of $5.3 million, thanks to cost controls. Free cash flow was around $3.8 million, and they reduced total debt to $132.7 million, aligning with their deleveraging plan. Despite set-asides, expansions on other contracts helped offset the revenue drop. The company is optimistic about the federal budget, with funding boosts for health agencies and swelling defense plus intelligence budgets, aligning with their strengths in AI, data science, and cyber. The pipeline is active with bids and a two-year sole-source extension on a key NIH contract. With awards pending and budgets favorable, DLH is poised to turn around the dip and secure organic growth wins. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4d7baec9db09dbdd